# Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cisplatin-enriching-cancer-stem-cells-confer-multidrug-resistance-in-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lihui Wang,Xing Liu,Yong Ren,Jingyuan Zhang,Junli Chen,Wenlong Zhou,Wei Guo,Xiaoxuan Wang,Huiping Chen,Meng Li,Xiangzhong Yuan,Xun Zhang,Jingyu Yang,Chunfu Wu |
| Citations | 134 |
| DOI | 10.1038/cddis.2016.409 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/cddis2016409.pdf |
| OpenAlex ID | https://openalex.org/W2606773425 |
| PMID | 28406482 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Xing Liu](https://scholariq.org/researchers/xing-liu/)

## Paper journal

- [Cell Death and Disease](https://scholariq.org/journals/cell-death-and-disease/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.